Discussion
==========

Smart devices are nearing ubiquity. Since their development, these devices continue to increase the local and global connectivity of people and improve our access to information. In 2015, there was an estimated 3.5 devices for every human on earth, and it is predicted that there will be a doubling of Internet-enabled mobile devices to 50 billion devices by 2020 (6.6 devices per person).[@b1-dmso-9-213] In conjunction with the creation of smart devices has been the birth of commercial markets to complement these devices, including the development of mobile applications or "apps", as well as tools and sensors intended to be operated through or paired with the device. The Mobile Health, or mHealth, industry holds a large portion of this market, and the demand for improvements in individual health behaviors has driven this market forward with the development of apps to assist in health improvement. Furthermore, the desire of humans to "self-digitize" has driven the development of internal sensors and remote tools for tracking of health and behaviors. Remote tools, including pedometers, accelerometers, bathroom scales, pill bottles, and blood pressure cuffs, are paired with these devices through apps to allow the user to interpret their own data and self-monitor health behaviors such as tracking of food intake, physical activity, body weight, sleep quality and duration, blood sugar, and blood pressure ([Figure 1](#f1-dmso-9-213){ref-type="fig"}). These products operate through the collection and transmission of empirical data to the smart device, which allows for real-time, objective self-monitoring. The more sophisticated apps are able to interpret these data and provide near real-time feedback to the user.

Our global population is connected and engaged in an ideal environment for dissemination of information because of the increased availability of Internet-enabled devices and rapid development of complementary products (apps, sensors, and tools). Indeed, these devices present opportunity to build upon the scalability, feasibility, and efficacy of traditional in-person treatment for weight loss or maintenance. For example, in the US, more than two-thirds of adults have a body mass index \>25 kg/m^2^ and \>140 million of these adults are eligible for weight loss treatment.[@b2-dmso-9-213] While the gold standard for weight loss treatment is an in-person approach (14 in-person contacts over 6 months) with personalized goals, advice, and feedback,[@b3-dmso-9-213] the Academy of Nutrition and Dietetics reports only 94,671 registered dietitian nutritionists in the US as of February 2016.[@b4-dmso-9-213] If all registered dietitian nutritionists were exclusively working to deliver weight loss treatment, this would yield a patient:provider ratio of \~1,500:1, suggesting that the in-person model for implementing weight loss treatment to all individuals is currently grossly inadequate. Hence, the ability to *increase scalability* of weight management programs is an obvious benefit of a smart device-based model compared to the traditional, in-person model. Reduction in cost and time for both patient and provider supports the *feasibility* of smart device-driven models. Apps disseminating smoking cessation interventions have extensively demonstrated that apps have the ability to serve as a platform for delivery of behavioral interventions.[@b5-dmso-9-213] In fact, mHealth technology allows for implementation of behavior change therapies because it retains the principles with which in-person treatment derives success: frequent engagement, consistency over time, and feedback on behavior. Provision of the near real-time feedback that mHealth interventions allow supports the potential for the *efficacy* of smart device models to be equivalent to the in-person model. Indeed, computer code can be easily developed to interpret user data and deliver automated near real-time feedback from providers congruent with patient data collected via these tools ([Figure 1](#f1-dmso-9-213){ref-type="fig"}). For example, tracking food intake or recording number of steps/day using a pedometer has been shown in clinical trials to produce more successful weight and behavior change.[@b6-dmso-9-213]--[@b8-dmso-9-213] Although apps have been shown to be capable of delivering behavior change theories, reviews of content analysis of commercially available physical activity and weight management apps have shown very poor inclusion of behavioral change theories.[@b9-dmso-9-213],[@b10-dmso-9-213] In fact, in a review of 204 commercially available weight loss apps, none of the apps reviewed included all 13 evidence-informed practices for weight loss the authors identified common to the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Food and Drug Administration (FDA), and US Department of Agriculture (USDA): 1) assess one's weight, 2) eat a diet rich in fruits and vegetables, 3) perform regular physical activity, 4) drink water instead of juice or soda, 5) keep a food diary, 6) maintain calorie balance of in versus out, 7) weight loss of 1--2 lb/wk, 8) portion control, 9) read nutrition labels, 10) track your weight, 11) keep a physical activity journal, 12) plan meals, and 13) seek social support.[@b11-dmso-9-213] Only 21% of apps studied recommended regular physical activity, 6% recommended a weight loss goal of 1--2 pounds/wk, and only 36% of these apps even assessed the user's weight at all (ie, calculated the user's body mass index).[@b11-dmso-9-213] It also remains to be determined whether behavioral economics in favor of the patient and provider are also realized by the increased use of smartphones in health care delivery system.[@b12-dmso-9-213]

The mHealth market is booming, but is the science keeping up? Evaluated at \$10.5 billion in 2014, this market is projected to reach \~\$60 billion by 2020 with a compound annual growth rate of \>30%.[@b13-dmso-9-213] As the mHealth market continues to grow, smart devices and their associated apps, sensors, and tools are increasingly available at progressively affordable costs. As of February 11, 2016, \>60,000 "Health & Fitness" apps were commercially available to Android consumers (Android accounts for an estimated 50% of the mobile device market).[@b14-dmso-9-213] Additionally, demonstrating the growth of market for tools, Fitbit Inc. (a company that produces wearable fitness trackers founded in 2007) reported an increased revenue from \$745 million in 2014 to \$1.858 billion in 2015.[@b15-dmso-9-213]

Similar to the dietary supplement market, the anecdotal value of these products has driven their popularity and acceptance by the general public without requirement of scientific validation or, in the area of weight management or diet/exercise, approval by the FDA prior to market launch. To this point, a search of [clinicaltrials.gov](http://clinicaltrials.gov) (accessed February 5, 2016) using terms "smartphone, mobile phone, app, application, and weight" identified 56 registered research studies, of which only 16 were randomized controlled trials (RCTs) testing weight loss/maintenance programs delivered by smart device application compared to either no intervention or in-person intervention.[@b16-dmso-9-213] A search of [PubMed.gov](http://PubMed.gov) (accessed February 5, 2016) with the same keywords (smartphone, mobile phone, app, application, and weight, filters: English and humans) produced 65 search results, of which only six citations were a) RCTs and b) testing the efficacy of smart device application.[@b17-dmso-9-213] Perhaps, it is the ubiquity of these devices and their products, which has led much of the scientific community to trust the very few RCTs supporting the efficacy of delivering interventions remotely via apps. Many clinical trials in fact have incorporated common commercially available applications to aid in data collection or intervention support (e.g., Lose It! to track food intake), while RCTs testing the efficacy of these apps are still lacking. Consequently, there is an increasingly large gap between production and dissemination of products and proof of their efficacy and safety. The speedy development-to-dissemination rate of technology can be intimidating for researchers and can impede the ability for appropriate testing of effectiveness. An app that winds up being tested in an RCT will likely be outdated by the time the results are published and even more outdated before it can be integrated into clinical practice. However, it does not negate the necessity for validation. Perhaps, testing general principles, for example, the inclusion of common evidence-informed practices or implementation of behavior change strategies, delivered remotely through apps versus the in-person model may be a more advantageous path to determine the efficacy of these products.

We are living within a hyperconnected new age of technology, where smart devices and smart device products are nearly ever-present, and the vast majority of the world population has immediate access to the Internet. Simultaneously, we are arguably living among the sickest and heaviest population yet, and the in-person model for dissemination of weight loss/maintenance programs is unsustainable to successfully reach the world's health goals.[@b18-dmso-9-213] Considering the potential aforementioned benefits, implementing weight management programs using smart devices could potentially lessen health care system costs and burden (as well as the burden of the patient), increase scalability of dissemination, and improve efficacy of a program, but there is a dire need of controlled RCTs and published peer-reviewed data. Research efforts must be focused on illuminating the efficacy of behavioral interventions and remote self-monitoring for weight loss/maintenance treatment with true RCTs.
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